Related Experiment Video
Updated: Jul 15, 2026
10:14
Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Value-based medicine and interventions for macular degeneration.
Melissa M Brown1, Gary C Brown, Heidi Brown
1Center for Value-Based Medicine, Flourtown, USA. mbrown@valuebasedmedicine.com
Current Opinion in Ophthalmology
|April 17, 2007
Summary
Interventions for neovascular macular degeneration, particularly ranibizumab therapy, offer substantial patient value, significantly improving quality of life compared to other medical treatments. This review highlights the high value gain in ophthalmology.
Area of Science:
- Ophthalmology
- Value-based medicine
- Health economics
Background:
- Neovascular macular degeneration (NMD) significantly impacts patient quality of life.
- Value-based medicine prioritizes interventions based on patient value, defined as improved quality and length of life.
- In ophthalmology, value gain primarily reflects quality of life improvements.
Purpose of the Study:
- To review and quantify the patient value conferred by interventions for neovascular macular degeneration.
- To compare the value of NMD treatments with other common medical interventions.
Main Methods:
- Review of existing literature on interventions for neovascular macular degeneration.
- Analysis of patient value gain, measured as improvement in quality of life.
- Comparative analysis of value gain across different NMD therapies and other medical treatments.
Main Results:
- Photodynamic therapy for classic subfoveal choroidal neovascularization yields an 8.1% quality of life improvement.
- Laser photocoagulation confers a 4.4% quality of life improvement for the same condition.
- Ranibizumab therapy for occult/minimally classic NMD shows a preliminary value gain exceeding 15%, significantly higher than statins (3.9%), bisphosphonates (1.1%), or benign prostatic hyperplasia drugs (1-2%).
Conclusions:
- Interventions for neovascular macular degeneration, especially ranibizumab, provide exceptional patient value.
- NMD treatments demonstrate a significantly higher value gain compared to numerous other healthcare interventions.
- These findings support the high efficacy and patient benefit of advanced NMD therapies within a value-based healthcare framework.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...